[1]
Liu, D. et al. 2025. The efficacy and safety of biologic or targeted synthetic DMARDs in rheumatoid arthritis treatment: one year of review 2024. Allergologia et Immunopathologia. 53, 3 (May 2025), 140–162. DOI:https://doi.org/10.15586/aei.v53i3.1278.